chartexchange

Evommune signs $1.1bn licence deal with Hinova for EVO570

Pharmaceutical Technology | Nov 5, 2026 5:36 AM EST

Evommune has secured exclusive rights outside Greater China to develop EVO570 from Hinova Pharmaceuticals in a deal worth up to $1.1bn.

Read original article